College of Contemporary Health

03/08/2026

Adding one avocado to the daily diet may reduce heart disease risk in adults living with obesity, according to research led by the Penn State University Department of Nutritional Sciences and published in the Journal of Clinical Lipidology.

The team found that regular consumption was associated with a lower concentration of low-density lipoprotein (LDL) particles – the protein particles that transport cholesterol around the body – in the blood.

That reduction corresponded to an approximate 4% decrease in risk.

What distinguishes the finding is its modesty.

Rather than testing a wholesale dietary overhaul, the researchers examined what happens when people make one addition and otherwise carry on as normal.

A Penn State study found adults living with obesity who ate one avocado daily cut LDL particle levels by 49 nmol/L – around a 4% lower heart disease risk. (154 characters)

03/08/2026

Fits and starts or a coherent journey?

In the healthcare profession, it is quite common to complete a training, then decide to look for the next one later on. Months can pass in between – or the next one never happens at all.

In GLP-1RA care, added risk arises with that gap:

The dose that was never quite right.

The consult that stalled because the explaination of what's going on didn't land.

The plateau read as failure instead of physiology .

𝐆𝐋𝐏-1𝐑𝐀 𝐓𝐡𝐞𝐫𝐚𝐩𝐲: 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐏𝐫𝐨𝐠𝐫𝐚𝐦𝐦𝐞 covers all three: Understand, Prescribe, Support.

This is what turns fits and starts into a coherent journey.

𝐅𝐮𝐥𝐥 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐚𝐧𝐝 𝐞𝐧𝐫𝐨𝐥𝐦𝐞𝐧𝐭: https://www.contemporaryhealth.co.uk/glp-1ra-ozempic-mounjaro-complete-course-for-hcps/

---

About the Complete Programme:

🔹 £147 – the same as buying the three courses individually
🔹 Includes a capstone case study that brings your GLP-1RA judgement together, plus the CCH Advanced Certificate

---

29/07/2026

Medications from the GLP-1 receptor agonist class, now widely used in the management of type 2 diabetes and , may be associated with a modest increase in .

The finding comes from a study published by The BMJ on 22 July 2026.

The class includes semaglutide, marketed under brand names such as and Wegovy, and tirzepatide, marketed as and Zepbound.

Researchers found that adults living with type 2 who were treated with receptor agonists went on to develop alopecia more frequently than people prescribed two other commonly used classes of diabetes medication.

A BMJ study links Ozempic and Mounjaro hair loss to a modest rise in alopecia risk in type 2 diabetes care, though the absolute risk remains low.

28/07/2026

Semaglutide and liraglutide are not interchangeable, and the difference is not academic – it shapes what you can honestly tell a patient about what to expect.

If you can only give the broad strokes, you are not alone. If you can actually explain it, clearly, you are ahead of the curve.

What would you say?

---

28/07/2026

Generative artificial intelligence ( ) chatbots designed to support are winning people over on experience, but the research needed to establish whether they are safe and clinically effective has not kept pace.

That is the central finding of a review, currently in press in the journal npj Digital Medicine (Springer Nature), which examined the user experience (UX) and intervention design of GenAI mental health .

A review of 21 studies finds people rate AI mental health chatbots highly for convenience and empathy – but clinical benefit and safety remain unproven.

27/07/2026

People living with type 2 carry much of the day-to-day work of managing their condition.

Self-monitoring, medication adherence, lifestyle modification and psychosocial coping all fall largely to the individual, supported at intervals by their clinical team.

Comprehensive has been proposed as a way of closing the gaps between those intervals – enabling more regular contact with health care providers, structured review of patient-generated data, and input from a multidisciplinary team without requiring people to attend in person.

What has remained uncertain is whether that model works in a fee-for-service setting, where reimbursement structures and service design differ markedly from the integrated systems in which much telehealth research has been conducted.

A randomised trial published in Annals of Internal Medicine set out to answer that question.

A randomised trial of telehealth for type 2 diabetes found significant self-care gains but only modest, non-significant improvements in glycaemic control.

24/07/2026

People living with overweight or can carry a higher risk of even when they appear to be perfectly healthy, according to new research presented at the International Congress on Obesity in Mexico City (15–17 July).

Combining waist-based measurements with body mass index ( ) to detect this hidden risk and act early could, over the years ahead, prevent hundreds of thousands of people from dying from heart attacks, strokes and other cardiac problems, researchers from the University of Glasgow, Glasgow, UK, said.

23/07/2026

Patients are increasingly taking charge of their own healthcare with and other , with 58% of US patients researching their symptoms before deciding whether to book an appointment, according to a new report from the ZS Impact Institute.

The report drew on insights from nearly 10,000 consumers and providers across the US, Germany and China.

Researchers note that the shift is consistent across healthcare systems – a pattern they say points to a “broader breakdown in how patients seek and experience care globally.”

A new ZS Impact Institute report finds AI in healthcare decision-making is changing how patients research symptoms and choose when to seek care.

22/07/2026

Interest in continues to surge, and it has now risen to the top of the priority list for organisations across most major markets outside the United States.

According to a new report from KLAS Research, the share of organisations naming as a strategic initiative climbed by 15 percentage points year on year – a striking marker of how quickly the has moved from experiment to strategic imperative.

A new KLAS report finds AI is now the top healthcare IT investment priority in most markets outside the US, ahead of EHRs, cybersecurity and imaging.

21/07/2026

A soft, pneumatic glove developed at the TU München is giving people with a way to grasp objects once more.

The device was created by researchers at the TUM Chair of Cognitive Systems, who use electrical signals from the forearm muscles to reliably predict the moment a person intends to reach for something.

Its designers believe it could one day support people whose hands have been paralysed as a result of accidents or neurological disorders. The research is published in the journal Nature Machine Intelligence.

A low-cost smart exoskeleton glove from TUM helps people with hand paralysis grasp everyday objects – one man held a fork for the first time in four years.